Rod A. Porter

3.4k citations

25 papers · 1.6k indexed · h-index 16

Impact in

Endocrine and Autonomic Systems top 0.5%
- Circadian rhythm and melatonin
- Regulation of Appetite and Obesity
Experimental and Cognitive Psychology top 2%
- Sleep and related disorders

Papers in

Endocrine and Autonomic Systems 10
- Regulation of Appetite and Obesity 8
Experimental and Cognitive Psychology 10
- Sleep and related disorders 10

Co-authors: Amanda Johns Stephen Brough Jeffrey C. Jerman N. Upton Phil Jeffrey D Smart Frances Jewitt Scott Summerfield
Journals: Tetrahedron Letters (2 papers)Behavioural Brain Research (2 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Psychopharmacology (2 papers)British Journal of Pharmacology (2 papers)
Partner nations: United Kingdom United States Netherlands

In The Last Decade

Rod A. Porter

25 papers receiving 1.6k citations

Peers

Countries citing papers authored by Rod A. Porter

Since Specialization

Citations

This map shows the geographic impact of Rod A. Porter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rod A. Porter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rod A. Porter more than expected).

Fields of papers citing papers by Rod A. Porter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rod A. Porter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rod A. Porter. The network helps show where Rod A. Porter may publish in the future.

Co-authors

The 25 scholars most cited alongside Rod A. Porter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rod A. Porter Line = papers co-authored together Rod A. Porter links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Orexin receptors in GtoPdb v.2023.1 IUPHAR/BPS Guide to Pharmacology CITE ·Gary Aston‐Jones, Pascal Bonaventure, Paul J. Coleman, Luı́s de Lecea, G. De Canio, Daniël Hoyer, Laura H. Jacobson, Thomas S. Kilduff, Jyrki P. Kukkonen, T. P. McDonald, Rod A. Porter, John J. Renger, Takeshi Sakurai, Jerome M. Siegel, D.M. Bustos, Neil Upton, Christopher J. Winrow, Masashi Yanagisawa	2023	2
2	Orexin receptors in GtoPdb v.2021.3 IUPHAR/BPS Guide to Pharmacology CITE ·Paul J. Coleman, Luı́s de Lecea, Anthony L. Gotter, Jim J. Hagan, Daniël Hoyer, Thomas S. Kilduff, Jyrki P. Kukkonen, Rod A. Porter, John J. Renger, Jerome M. Siegel, D.M. Bustos, Neil Upton, Christopher J. Winrow	2021	3
3	Identification and evaluation of [¹¹C]GSK931145 as a novel ligand for imaging the type 1 glycine transporter with positron emission tomography Synapse ·Jan Passchier, Gabriella Gentile, Rod A. Porter, Hugh J. Herdon, Cristian Salinas, Steen Jakobsen, سارا جعفریان, Marc Laruelle, Roger N. Gunn	2010	27
4	Pharmacological characterisation of the GlyT-1 glycine transporter using two novel radioligands Neuropharmacology ·Hugh J. Herdon, Jennifer Roberts, Simon Coulton, Rod A. Porter	2010	18
5	Glycine transporter 1 (GlyT1) inhibitors exhibit anticonvulsant properties in the rat maximal electroshock threshold (MEST) test Brain Research ·Mikhail Kalinichev, Kathryn R. Starr, Simon J. Teague, I︠u︡. N. Nika, Rod A. Porter, Hugh J. Herdon	2010	16
6	Receptor Occupancy and Brain Free Fraction Drug Metabolism and Disposition ·Jeanette Watson, Laith Abualloush, Adam Lucas, M L Chen, Jean Viggers, Sharon C. Cheetham, Phil Jeffrey, Rod A. Porter, Kevin D. Read	2009	80
7	Toward an improved prediction of humanin vivobrain penetration Xenobiotica ·Scott Summerfield, Adam Lucas, Rod A. Porter, Phil Jeffrey, Roger N. Gunn, Anupam Pradhan, Alexander J. Stevens, Moobeom Hong, S. S. Guravleva, Peter Kilford, Jan Passchier, Duncan Wright	2008	77
8	New quinoline NK3 receptor antagonists with CNS activity Bioorganic & Medicinal Chemistry Letters ·Paul W. Smith, Paul Wyman, Peter J. Lovell, 김옥배, Halina T. Serafinowska, Antonio Vong, Frank P. Harrington, 益田順一, 孙长安, Rod A. Porter, Sara Coggon, G.S. Murkitt, N. V. Yakymchuk, David R. Thomas, Jeannette M. Watson, William Martin, Zining Wu, Lee A. Dawson	2008	45
9	Central Nervous System Drug Disposition: The Relationship between in Situ Brain Permeability and Brain Free Fraction Journal of Pharmacology and Experimental Therapeutics ·Scott Summerfield, Kevin D. Read, David J. Begley, Tanja Obradovic, Ismael J. Hidalgo, Sara Coggon, Catrin Swantje Müller, Rod A. Porter, Phil Jeffrey	2007	225
10	Satiety enhancement by selective orexin-1 receptor antagonist SB-334867: influence of test context and profile comparison with CCK-8S Behavioural Brain Research ·Yasuyuki Ishii, John E. Blundell, Jason C. G. Halford, N. Upton, Rod A. Porter, Amanda Johns, R.J. Rodgers	2004	35
11	Characterisation of the binding of [³H]‐SB‐674042, a novel nonpeptide antagonist, to the human orexin‐1 receptor British Journal of Pharmacology ·Christopher J. Langmead, Jeffrey C. Jerman, Stephen Brough, Claire M. Scott, Rod A. Porter, Hugh J. Herdon	2004	105
12	Anorexia and weight loss in male rats 24h following single dose treatment with orexin-1 receptor antagonist SB-334867 Behavioural Brain Research ·Yasuyuki Ishii, John E. Blundell, Jason C. G. Halford, N. Upton, Rod A. Porter, Amanda Johns, Philip D. Jeffrey, Scott Summerfield, R.J. Rodgers	2004	55
13	SB‐334867, a selective orexin‐1 receptor antagonist, enhances behavioural satiety and blocks the hyperphagic effect of orexin‐A in rats European Journal of Neuroscience ·R.J. Rodgers, Jason C. G. Halford, (unknown), D. A. Avergonzado, D.C Piper, Jonathan R.S. Arch, N. Upton, Rod A. Porter, Amanda Johns, John E. Blundell	2001	196
14	Effects of centrally administered orexin-B and orexin-A: a role for orexin-1 receptors in orexin-B-induced hyperactivity Psychopharmacology ·Declan N.C. Jones, Jane Gartlon, Frederick B. Parker, Stephen G. Taylor, Carol Routledge, Erika Lorenzo Vivas, Lee R Perkins, Tracey Ashmeade, Jonathan P. Hatcher, Amanda Johns, Rod A. Porter, Jim J. Hagan, A. Jackie Hunter, Neil Upton	2001	78
15	Evidence that orexin-A-evoked grooming in the rat is mediated by orexin-1 (OX 1 ) receptors, with downstream 5-HT 2C receptor involvement Psychopharmacology ·Mark Duxon, Tamara Raiza Gomes de Andrade, Kathryn R. Starr, Declan N.C. Jones, Vicky Holland, Graham J. Riley, Jeff Jerman, Stephen Brough, Darren Smart, Amanda Johns, Wai N. Chan, Rod A. Porter, Neil Upton	2001	79
16	Orexin-A, an hypothalamic peptide with analgesic properties Pain ·Sharon Bingham, Philip T. Davey, 剛司堀口, Elaine Irving, Aceng Hobir, Dimas Aulia Arzaqi, Philip D. Jeffrey, Leanne Cutler, Abdullah Abusorrah, Amanda Johns, Rod A. Porter, N. Upton, A. Jackie Hunter, Andrew A. Parsons	2001	234
17	Orexin‐A, an hypothalamic peptide with analgesic properties. (SmithKline Beecham Pharmaceuticals, Harlow, Essex, United Kingdom) Pain. 2001;92:81–90. Pain Practice ·Sharon Bingham, Philip T. Davey, Ioana Popa, Elaine Irving, Aceng Hobir, Dimas Aulia Arzaqi, Philip D. Jeffrey, Leanne Cutler, Abdullah Abusorrah, Amanda Johns, Rod A. Porter, N. Upton, A. Jackie Hunter, Andrew A. Parsons	2001	1
18	SYNTHESIS OF EXOCYCLIC ENAMIDES VIA STEREOCONTROLLED ALLYLIC ISOMERIZATION AND 1,3-TRANSPOSITION Synthetic Communications ·مریم قنبریان شیاده, Charles M. Marson, Rod A. Porter	2001	5
19	SB‐334867‐A: the first selective orexin‐1 receptor antagonist British Journal of Pharmacology ·D Smart, Cibele Sabido-David, Stephen Brough, Frances Jewitt, Amanda Johns, Rod A. Porter, Jeffrey C. Jerman	2001	269
20	N-1 substituted pyrimidin-4-ones: novel, orally active inhibitors of lipoprotein-associated phospholipase A2 Bioorganic & Medicinal Chemistry Letters ·Helen Boyd, A Bombik, 益田順一, Deirdre M. B. Hickey, Robert J. Ife, Colin A. Leach, Colin H. Macphee, Kevin J. Milliner, Kitty Moores, Ivan L. Pinto, Rod A. Porter, Xiong Ke, Stephen A. Smith, Ian Stansfield, David G. Tew, Colin J. Theobald, L. Miron	2000	24

About Rod A. Porter

Rod A. Porter is a scholar working on Endocrine and Autonomic Systems, Experimental and Cognitive Psychology, Cognitive Neuroscience, Biochemistry and Cellular and Molecular Neuroscience, having authored 25 papers that have together received 1.6k indexed citations. Recurring topics across this work include Sleep and Wakefulness Research (11 papers), Sleep and related disorders (10 papers), Regulation of Appetite and Obesity (8 papers), Neuroscience and Neuropharmacology Research (5 papers), Receptor Mechanisms and Signaling (4 papers), Amino Acid Enzymes and Metabolism (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Oxidative Organic Chemistry Reactions (3 papers). The work is most often cited by research in Endocrine and Autonomic Systems (900 citations), Experimental and Cognitive Psychology (645 citations), Cognitive Neuroscience (949 citations), Cellular and Molecular Neuroscience (279 citations) and Neurology (67 citations). Rod A. Porter has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Amanda Johns, Stephen Brough, Jeffrey C. Jerman, N. Upton, Phil Jeffrey, D Smart, Frances Jewitt, Scott Summerfield, Cibele Sabido-David and Kevin D. Read. Their work appears in journals such as Tetrahedron Letters, Behavioural Brain Research, Bioorganic & Medicinal Chemistry Letters, Psychopharmacology and British Journal of Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact